• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食管癌切除术后左锁骨上窝的辐射剂量对吻合口漏至关重要——剂量学结果分析

The Radiation Dose to the Left Supraclavicular Fossa is Critical for Anastomotic Leak Following Esophagectomy - A Dosimetric Outcome Analysis.

作者信息

Chou Shang-Yu, Lu Hung-I, Chen Yen-Hao, Lo Chien-Ming, Lin Yun-Hsuan, Huang Tzu-Ting, Fang Fu-Min, Chen Li-Chun, Chen Yu, Chiu Yi-Chun, Chou Yeh-Pin, Li Shau-Hsuan, Wang Yu-Ming

机构信息

Department of Radiation Oncology & Proton and Radiation Therapy Center, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.

Department of Thoracic & Cardiovascular Surgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.

出版信息

Cancer Manag Res. 2022 May 2;14:1603-1613. doi: 10.2147/CMAR.S354667. eCollection 2022.

DOI:10.2147/CMAR.S354667
PMID:35530530
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9075167/
Abstract

PURPOSE

For locally advanced esophageal cancer, definitive concurrent chemoradiotherapy (CCRT) with a radiation dose of 50-50.4 Gy/25-28 Fx is prescribed, followed by adjuvant esophagectomy for better local control or salvage treatment if locoregional recurrence occurs. However, radiation injury before surgery may delay wound healing. We performed cervical anastomosis directly inside the left supraclavicular fossa (SCF), the irradiation target for esophageal cancer. The significance of radiation injury in patients with cervical anastomotic leak (AL) remains unclear. Thus, we assessed the influence of radiation on cervical AL in patients undergoing preoperative CCRT followed by esophagectomy.

PATIENTS AND METHODS

We defined the SYC zone, a portion of the region overlapping the left SCF. The radiation dose to the SYC zone was analyzed and correlated with AL in patients with locally advanced esophageal squamous cell carcinoma (ESCC) who were administered preoperative CCRT (radiation dose with 50-50.4 Gy/25-28 Fx to the primary esophageal tumor) followed by esophagectomy between October 2009 and January 2018. Receiver operating characteristic curve analysis and logistic regression were used to identify the optimal radiation factor to predict AL and the cutoff value.

RESULTS

The optimal radiation factor to predict AL was the mean dose to the SYC zone (area under the curve (AUC)=0.642), and the cutoff point of the mean dose was 48.55 Gray (Gy). For a mean SYC zone dose ≥48.55 Gy, the AL risk was sevenfold greater than that for <48.55 Gy (OR = 7.805; 95% CI: 1.184 to 51.446; P value = 0.033).

CONCLUSION

Recognizing the SYC zone as an organ at risk and performing radiation evaluation are meaningful. A reduced mean dose of the SYC zone below 48.55 Gy results in a lower cervical AL rate following esophagectomy.

摘要

目的

对于局部晚期食管癌,规定采用50 - 50.4 Gy/25 - 28次分割的确定性同步放化疗(CCRT),随后进行辅助性食管切除术以实现更好的局部控制,或在发生局部区域复发时进行挽救性治疗。然而,手术前的放射性损伤可能会延迟伤口愈合。我们在左侧锁骨上窝(SCF)内直接进行颈部吻合术,此处是食管癌的照射靶区。放射性损伤对颈部吻合口漏(AL)患者的影响尚不清楚。因此,我们评估了术前CCRT后行食管切除术患者中放疗对颈部AL的影响。

患者与方法

我们定义了SYC区,即与左侧SCF重叠的部分区域。分析了2009年10月至2018年1月期间接受术前CCRT(对原发性食管肿瘤的放射剂量为50 - 50.4 Gy/25 - 28次分割)后行食管切除术的局部晚期食管鳞状细胞癌(ESCC)患者SYC区的放射剂量,并将其与AL进行相关性分析。采用受试者工作特征曲线分析和逻辑回归来确定预测AL的最佳放射因素及临界值。

结果

预测AL的最佳放射因素是SYC区的平均剂量(曲线下面积(AUC)=0.642),平均剂量的临界值为48.55格雷(Gy)。对于SYC区平均剂量≥48.55 Gy的患者,AL风险比<48.55 Gy的患者高7倍(OR = 7.805;95%置信区间:1.184至51.446;P值 = 0.033)。

结论

将SYC区视为危险器官并进行放射评估是有意义的。将SYC区的平均剂量降低至48.55 Gy以下可降低食管切除术后颈部AL的发生率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c802/9075167/695886b8cfe7/CMAR-14-1603-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c802/9075167/d7884e8303a5/CMAR-14-1603-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c802/9075167/695886b8cfe7/CMAR-14-1603-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c802/9075167/d7884e8303a5/CMAR-14-1603-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c802/9075167/695886b8cfe7/CMAR-14-1603-g0002.jpg

相似文献

1
The Radiation Dose to the Left Supraclavicular Fossa is Critical for Anastomotic Leak Following Esophagectomy - A Dosimetric Outcome Analysis.食管癌切除术后左锁骨上窝的辐射剂量对吻合口漏至关重要——剂量学结果分析
Cancer Manag Res. 2022 May 2;14:1603-1613. doi: 10.2147/CMAR.S354667. eCollection 2022.
2
High dose radiation with chemotherapy followed by salvage esophagectomy among patients with locally advanced esophageal squamous cell carcinoma.大剂量放疗联合化疗后挽救性食管切除术治疗局部晚期食管鳞癌。
Thorac Cancer. 2017 May;8(3):219-228. doi: 10.1111/1759-7714.12427. Epub 2017 Mar 21.
3
Effectiveness of esophagectomy in patients with thoracic esophageal squamous cell carcinoma receiving definitive radiotherapy or concurrent chemoradiotherapy through intensity-modulated radiation therapy techniques.采用调强放射治疗技术对胸段食管鳞状细胞癌患者进行根治性放疗或同步放化疗后行食管切除术的疗效。
Cancer. 2017 Jun 1;123(11):2043-2053. doi: 10.1002/cncr.30565. Epub 2017 Feb 2.
4
Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma.食管鳞状细胞癌大剂量放化疗后的挽救性食管切除术
J Thorac Cardiovasc Surg. 2009 Jan;137(1):49-54. doi: 10.1016/j.jtcvs.2008.05.016.
5
Radiation dose does not influence anastomotic complications in patients with esophageal cancer treated with neoadjuvant chemoradiation and transhiatal esophagectomy.对于接受新辅助放化疗和经裂孔食管切除术治疗的食管癌患者,辐射剂量并不影响吻合口并发症。
Radiat Oncol. 2015 Mar 6;10:59. doi: 10.1186/s13014-015-0361-4.
6
Concurrent chemoradiotherapy with twice weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal cancer.同步放化疗联合每周两次紫杉醇和顺铂,随后行手术切除治疗局部晚期食管癌。
Ann Oncol. 2007 Jan;18(1):93-98. doi: 10.1093/annonc/mdl339. Epub 2006 Oct 6.
7
Anastomotic complications after Ivor Lewis esophagectomy in patients treated with neoadjuvant chemoradiation are related to radiation dose to the gastric fundus.新辅助放化疗后行 Ivor Lewis 食管癌切除术患者的吻合口并发症与胃底部的放射剂量有关。
Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):e513-9. doi: 10.1016/j.ijrobp.2011.05.071. Epub 2011 Oct 17.
8
Radiation to the Gastric Fundus Increases the Risk of Anastomotic Leakage After Esophagectomy.胃底接受放疗会增加食管癌切除术后吻合口漏的风险。
Ann Thorac Surg. 2016 Dec;102(6):1798-1804. doi: 10.1016/j.athoracsur.2016.08.027. Epub 2016 Oct 17.
9
Evaluation of preoperative risk factors and postoperative indicators for anastomotic leak of minimally invasive McKeown esophagectomy: a single-center retrospective analysis.微创McKeown食管切除术吻合口漏的术前危险因素及术后指标评估:单中心回顾性分析
J Cardiothorac Surg. 2019 Feb 28;14(1):46. doi: 10.1186/s13019-019-0864-4.
10
Do We Need to Add Postoperative Radiotherapy in Patients Undergoing Trimodality Therapy for Esophageal Squamous Cell Carcinoma with Positive Lymph Nodes Disease?对于伴有阳性淋巴结疾病的食管鳞状细胞癌接受三联疗法的患者,我们是否需要添加术后放疗?
Dig Surg. 2018;35(2):104-110. doi: 10.1159/000477264. Epub 2017 Jul 4.

本文引用的文献

1
Intrathoracic vs Cervical Anastomosis After Totally or Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer: A Randomized Clinical Trial.胸内吻合与颈吻合在全胸腔镜或杂交微创食管癌根治术中的随机临床试验
JAMA Surg. 2021 Jul 1;156(7):601-610. doi: 10.1001/jamasurg.2021.1555.
2
Predictors of Anastomotic Leak After Esophagectomy for Cancer: Not All Leaks Increase Mortality.食管癌切除术后吻合口漏的预测因素:并非所有漏口都会增加死亡率。
Am Surg. 2021 Jun;87(6):864-871. doi: 10.1177/0003134820956329. Epub 2020 Nov 24.
3
Mortality After Esophagectomy: Analysis of Individual Complications and Their Association with Mortality.
食管癌手术后死亡率:单个并发症的分析及其与死亡率的关系。
J Gastrointest Surg. 2020 Sep;24(9):1948-1954. doi: 10.1007/s11605-019-04346-2. Epub 2019 Aug 13.
4
Relative Incremental Cost of Postoperative Complications of Esophagectomy.食管癌术后并发症的相对增量成本。
Semin Thorac Cardiovasc Surg. 2019 Summer;31(2):290-299. doi: 10.1053/j.semtcvs.2018.10.010. Epub 2018 Nov 2.
5
Impact of postoperative complications on outcomes after oesophagectomy for cancer.食管癌手术后并发症对治疗结果的影响。
Br J Surg. 2019 Jan;106(1):111-119. doi: 10.1002/bjs.11000. Epub 2018 Oct 29.
6
Neck Lymph Node Metastasis as A Poor Prognostic Factor in Thoracic Esophageal Squamous Cell Carcinoma Patients Receiving Concurrent Chemoradiotherapy: A Propensity Score-Matched Analysis.颈淋巴结转移是接受同步放化疗的胸段食管鳞癌患者预后不良的因素:倾向评分匹配分析。
Sci Rep. 2018 Oct 10;8(1):15073. doi: 10.1038/s41598-018-33400-3.
7
Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial.新辅助放化疗联合手术对比单纯手术治疗局部进展期食管鳞癌(NEOCRTEC5010):一项 III 期、多中心、随机、开放标签临床试验。
J Clin Oncol. 2018 Sep 20;36(27):2796-2803. doi: 10.1200/JCO.2018.79.1483. Epub 2018 Aug 8.
8
Excess Cost and Predictive Factors of Esophagectomy Complications in the SEER-Medicare Database.SEER-Medicare 数据库中食管切除术并发症的超额成本及预测因素。
Ann Thorac Surg. 2018 Nov;106(5):1484-1491. doi: 10.1016/j.athoracsur.2018.05.062. Epub 2018 Jun 23.
9
The clinical impact of supraclavicular lymph node metastasis in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy.根治性同步放化疗治疗局部晚期食管鳞癌患者锁骨上淋巴结转移的临床影响。
PLoS One. 2018 Jun 11;13(6):e0198800. doi: 10.1371/journal.pone.0198800. eCollection 2018.
10
Treatment Outcomes of Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy.局部晚期同步食管和头/颈鳞状细胞癌患者接受根治性同期放化疗的治疗结果。
Sci Rep. 2017 Jan 30;7:41785. doi: 10.1038/srep41785.